| Literature DB >> 11686878 |
Abstract
Airway neuroepithelial bodies sense changes in inspired O2, whereas arterial O2 levels are monitored primarily by the carotid body. Both respond to hypoxia by initiating corrective cardiorespiratory reflexes, thereby optimising gas exchange in the face of a potentially deleterious O2 supply. One unifying theme underpinning chemotransduction in these tissues is K+ channel inhibition. However, the transduction components, from O2 sensor to K+ channel, display considerable tissue specificity yet result in analogous end points. Here we highlight how emerging data are contributing to a more complete understanding of O2 chemosensing at the molecular level.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11686878 PMCID: PMC2002075 DOI: 10.1186/rr51
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Figure 1Schematic flow diagram illustrating the diverse but converging transduction pathways linking hypoxia to transmitter release from arterial (carotid body) and airway (neuroepithelial body) chemoreceptors. Kv3.3 channel, voltage-activated shaw K+ channel (KCNC3); Maxi K, high-conductance, Ca2+-activated K+ channel (KCMA1); ROS, reactive oxygen species; TASK, TWIK-related, acid-sensitive K2P channel; TWIK, tandem of P-domains, weakly inward rectifying K2P channel.